TROP2 overexpression showed better overall survival in AdC patients by Kaplan-Meier analysis (median follow-up 39.6 months; range 2-123 months) (P = 0.02) (Figure 4A). This evidence concerns the gene TACSTD2 and AIDS dementia complex.